Judicial Review of EU Authorisation of Genetically Engineered Soybeans with Stacked Genes (MON 87701 x MON 89788)


 The Grounds upon which Testbiotech, ENSSER, and Sambucus challenge the Commission’s decision are, in summary:

Ground A: EFSA’s assessment that the Soybean is ‘substantially equivalent’ to its appropriate comparators is unlawful, is based on a scientific assessment which was not carried out in accordance with its own guidance, and/or is based on a manifest error of assessment;

Ground B: EFSA’s failure to give adequate or any consideration to the potential synergistic/combinatorial effects between the Soybean and other factors, and/or to require an adequate toxicity assessment to be conducted is contrary to its own guidance, legal obligations and/or it constitutes a manifest error of assessment;

Ground C: EFSA’s failure to require an adequate immunological assessment to be carried out is contrary to its own guidance, legal obligations and/or constitutes a manifest error of assessment.

Ground D: EFSA’s determination that no post-market authorisation monitoring of the consumption of the Soybean is manifestly in error and/or is vitiated by the flaws identified by Grounds A to C.

 

Further information

Press release: Lawsuit filed against EU authorisation of genetically engineered soybeans